31 completed. 31 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 31 | Completed 31 |
Follow Pertussis: new trials by email Literature Review of Pertussis trials Research Report on Pertussis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 10-year Follow-up After a Single Dose Acellular Pertussis Vaccination Pertagen® vaccine, Adacel® vaccine - Pertussis | Phase 4 | Completed | Mahidol University | 90 | 2025-05-13 | 2026-10-08 |
| Maternal Determinants of Infant Immunity to Pertussis Triaxis® (Pertussis-containing vaccine), Vaxelis® (Pertussis-containing vaccine) - Vaccination; Infection, Maternal-Fetal Relations | Phase 4 | Completed | Centre Hospitalier Universitaire Saint Pierre | 200 | 2023-09-12 | 2026-01-13 |
| Pertussis Vaccination in Pregnant Women Boostrix administered during gestational diabetes screening, Boostrix administered in high volume obstetric clinic - Pertussis | Phase 4 | Completed | St. Justine's Hospital | 946 | 2019-06-01 | 2021-09-24 |
| A Study Exploring Whooping Cough Protection in Children and Adults Boostrix®-IPV combination vaccine - Pertussis | Phase 4 | Completed | University of Oxford | 122 | 2018-04-18 | 2021-01-08 |
| Adacel® Booster Vaccination for CMI Assay Development Adacel® - Pertussis | Phase 4 | Completed | Dalhousie University | 10 | 2017-07-12 | 2020-09-10 |
| Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand Boostrix, Infanrix hexa, Quinvaxem - Pertussis | Phase 4 | Completed | Universiteit Antwerpen | 370 | 2015-04-01 | 2019-10-24 |
| Pertussis and Meningitis C Concomitant Vaccination in Adolescents Meningococcal vaccine, Pertussis containing vaccine - Pertussis, Meningitis | Phase 4 | Completed | Public Health England | 400 | 2013-09-01 | 2019-03-22 |
| Tdap Vaccine in Post-Partum Women Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum phosphate - Diphtheria, Pertussis | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 55 | 2012-10-26 | 2017-05-05 |
| Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age Meningococcal polysaccharide diphtheria toxoid conjugate, Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate - Meningitis, Meningococcal Infection | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1394 | 2012-07-01 | 2015-12-15 |
| Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®) - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 423 | 2012-06-01 | 2016-03-02 |
| Pertussis (Tdap) Vaccination in Pregnancy Pertussis vaccine - Pertussis, Pregnancy | Phase 4 | Completed | Universiteit Antwerpen | 99 | 2012-02-01 | 2019-10-24 |
| Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China DTacP IPV//PRP~T combined vaccine: PENTAXIM® - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 900 | 2011-12-01 | 2013-03-29 |
| Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine, Tetanus and Diphtheria Toxoids Adsorbed For Adult Use - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1330 | 2011-11-01 | 2022-04-28 |
| Regulatory Post-Marketing Surveillance Study for TETRAXIM™ TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 600 | 2011-06-01 | 2022-03-28 |
| Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination Quinvaxem, Quinvaxem/Tritanrix - Diphtheria, Pertussis | Phase 4 | Completed | Crucell Holland BV | 400 | 2011-05-01 | 2013-09-09 |
| Study of Adacel® Vaccine Administered to Persons 10 Years of Age Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi | 1302 | 2011-03-01 | 2016-04-08 |
| Post Marketing Surveillance for ADACEL™ in South Korea ADACEL™:Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 659 | 2010-06-01 | 2022-04-28 |
| Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age DTacP-IPV combined vaccine (TETRAXIM™) - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi | 123 | 2009-12-01 | 2011-10-05 |
| Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®) - Pertussis, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 769 | 2008-06-01 | 2014-04-30 |
| Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine Shan5 - Diphtheria, Tetanus | Phase 4 | Completed | Shantha Biotechnics Limited | 160 | 2008-03-01 | 2009-06-25 |
Showing 20 of 31. Sign in to see all of them.
Whooping Cough (31) · Diphtheria (23) · Tetanus (23) · Poliomyelitis (8) · Haemophilus Infections (7) · Hepatitis B (3) · Meningitis (3) · Meningococcal Infections (2) · Infant Death (1) · Infections (1) · Measles (1) · Virus Diseases (1)
Bacterial Infections (31) · Bacterial Infections and Mycoses (31) · Bordetella Infections (31) · Gram-Negative Bacterial Infections (31) · Respiratory Tract Diseases (31) · Respiratory Tract Infections (31) · Infections (30) · Actinomycetales Infections (23) · Clostridium Infections (23) · Corynebacterium Infections (23) · Gram-Positive Bacterial Infections (23) · Nervous System Diseases (11) · Neuroinflammatory Diseases (11) · Virus Diseases (11) · RNA Virus Infections (9)
adacel (12) · Tetanus Toxoid (10) · Boostrix (5) · Meningococcal Vaccines (3) · Pentavac (3) · Diphtheria-Tetanus Vaccine (2) · Pertussis Vaccine (2) · Diphtheria Toxoid (1) · Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · HibTITER protein, Haemophilus influenzae (1) · Measles Vaccine (1) · Poliovirus Vaccine, Inactivated (1) · Poliovirus Vaccine, Oral (1) · Sodium Chloride (1) · Vaccines (1)
Sanofi Pasteur, a Sanofi Company (11) · Sanofi (6) · Shantha Biotechnics Limited (2) · Universiteit Antwerpen (2) · Bandim Health Project (1) · Centre Hospitalier Universitaire Saint Pierre (1) · Crucell Holland BV (1) · Dalhousie University (1) · Mahidol University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Norwegian Institute of Public Health (1) · Public Health England (1) · St. Justine's Hospital (1) · University of Oxford (1)
United States (10) · Canada (5) · Thailand (4) · Belgium (2) · India (2) · Philippines (2) · South Korea (2) · United Kingdom (2) · China (1) · Finland (1) · Germany (1) · Guinea-Bissau (1) · Netherlands (1) · Norway (1) · Puerto Rico (1)
Raman Rao, MD (2) · Caroline Quach, MD (1) · Dr Dominic Kelly (1) · Dr Marlies van Houten (1) · Elke Leuridan, MD PhD (1) · Elke Leuridan, MD, PhD (1) · Maria RZ Capeding, MD (1) · Punnee Pitisuttithum (1) · Scott A Halperin, MD (1)
PMID 20616762, PMID 22115634, PMID 23077849, PMID 24176498, PMID 24835247, PMID 25230939, PMID 27142328, PMID 29438562, PMID 29573876, PMID 31301919, PMID 31418814, PMID 32331806, PMID 35135700, PMID 35575974, PMID 37285482, PMID 38752802, PMID 39066382, PMID 39385752, PMID 41122946